Back

Clinical experience and safety of ferric carboxymaltose for treating iron deficiency in heart failure patients with mildly reduced and preserved left ventricular ejection fraction.

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - clinical Comorbidities HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Alberto Esteban Fernandez

Severo Ochoa Hospital, Leganes (Spain)

7 More presentations in this session

Presentation thumbnail
GDF15 is linked to congestion-related anorexia and weight loss in advanced HF
Doctor V. Melenovsky (Prague, CZ)
Abstract Slides
Presentation thumbnail
Prognostic impact of co-morbidities on long-term prognosis in patients with reduced and preserved ejection fraction following acute myocardial infarction
Assistant Professor L. Savic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Soluble transferrin receptor as a marker of tissue iron deficiency: impact on health-related quality of life in patients with heart failure without systemic iron deficiency or anaemia
Mr R. Ramos Polo (Hospitalet De Llobregat, ES)
Abstract Slides
Presentation thumbnail
Infection risk with ferric derisomaltose compared to standard of care in patients with heart failure and iron deficiency: a prespecified analysis of the IRONMAN trial
Professor P. Kalra (Portsmouth, GB)
Abstract Slides
Presentation thumbnail
Evaluation of intracranial circulation in patients in terminal stage of heart failure before and after heart transplantation
Doctor J. Zizka (Prague, CZ)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - clinical

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023
You may be interested in
thumbnail
Congress Presentation
Therapeutic implications of the cardio-renal-metabolic multimorbidity
thumbnail
Congress Presentation
Prognostic implications of multimorbidity in patients with heart failure with mildly reduced ejection fraction
thumbnail
Congress Presentation
Obesity and inactivity cluster is the strongest predictor of incident heart failure in a population-based study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources